跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
找到 180 条关于
“IBC101”
全部
180
临床试验
110
药物
41
机构
0
资讯
29
25天前
Liminatus Pharma Engages Synex as CRO to Advance IBC101 CD19xCD22 Bivalent CAR-T Therapy in South Korea
3个月前
Liminatus Pharma to Acquire InnocsAI in $320 Million Deal, Gaining Next-Generation CAR-T Pipeline for Hematologic and Solid Tumors
去年
Liminatus Pharma Advances Second-Generation CD47 Inhibitor IBA101 Toward 2027 Clinical Trials
6个月前
Liminatus Pharma Plans Phase 1 Trial of IBA101 CD47-Blocking Antibody for Lung Cancer
去年
BioGenCell's Personalized Cell Therapy BGC101 Receives FDA Fast Track Designation for Critical Limb Threatening Ischemia
去年
HanchorBio's HCB101 Advances in Clinical Trials, Leading Novel CD47-Targeting Immunotherapy Pipeline
2年前
FDA Grants Fast Track Designation to ICT01 Plus Azacitidine and Venetoclax for AML
2年前
FDA Grants Priority Review to IntraBio's IB1001 for Niemann-Pick Disease Type C
去年
Triumvira Immunologics Presents Promising Phase 1 Data for TAC101-CLDN18.2 in Solid Tumors
去年
Biophytis' BIO101 Shows Promising Phase II Results in Sarcopenia Treatment, Advancing to Phase III
第 1 页,共 3 页
上一页
下一页